3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
6
Leukemia, Myeloid, Acute
4
Uveal Melanoma
2
Lymphoma
2
Leukemia
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Dysplasia
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Select Advanced Solid Tumors
1
Recurrence
1
Rectal Neoplasms
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Meningeal Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia, Myeloid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Kidney Diseases
1
Gastrointestinal Neoplasms
1
Interventions
Cisplatin
18
Gemcitabine
14
Radiotherapy, Intensity-Modulated
11
Magnetic Resonance Spectroscopy
8
toripalimab
7
Specimen Handling
7
Capecitabine
7
Platinum
5
Drug Therapy
5
1,2-diaminocyclohexaneplatinum II citrate
5
camrelizumab
4
Radiotherapy
4
Nivolumab
4
spartalizumab
3
sintilimab
3
anlotinib
3
Immunoglobulin G
3
Immune Checkpoint Inhibitors
3
Docetaxel
3
Disulfides
3
atezolizumab
2
Radiation
2
Phantoms, Imaging
2
Ipilimumab
2
Carboplatin
2
CTLA-4 Antigen
2
Biopsy
2
Bevacizumab
2
18-O-demethylcervinomycin A2
2
tislelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Interleukin-2
×
90 days
×
Clear all
No trials found.